Navigation Links
Watson to Host Second Quarter 2009 Earnings Conference Call and Webcast
Date:7/10/2009

MORRISTOWN, N.J., July 10 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the Company intends to release its second quarter 2009 financial results on Wednesday, July 29, 2009 prior to the open of the U.S. financial markets. The Company will also host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on July 29, 2009 to discuss its financial results and provide an update on the Company's outlook for 2009. The dial-in number to access the call is (877) 251-7980, or from international locations, (706) 643-1573.

A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Daylight Time on August 14, 2009. The replay may be accessed by dialing (800) 642-1687 and entering pass code 18892418. From international locations, the replay may be accessed by dialing (706) 645-9291 and entering the same pass code. To access the webcast, go to Watson's Investor Relations Web site at http://ir.watson.com. A replay of the webcast will also be available.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
2. Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
3. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
4. Watson to Acquire Arrow Group
5. Watson Files FDA Application for Generic Mucinex(R) D
6. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
7. Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009
8. Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
9. Watson Files FDA Applications for Generic Mucinex(R)
10. Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
11. Companies Continue To Add Wellness Programs, Watson Wyatt/National Business Group On Health Survey Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... Six greater Bay Area roller derby leagues ... “Make ‘em Bleed,” the most widely attended series of blood drives in California, beginning July ... blood over the past 4 years -- enough to have helped to save up to ...
(Date:7/26/2017)... (PRWEB) , ... July 26, ... ... for Pharmaceutical Engineering (ISPE) will host its 2017 Process Validation and ... concurrent events offer comprehensive solutions to process validation lifecycle challenges faced by ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... has opened in Jupiter. The state of the art center will provide ... treatments with a goal of providing heart patients longer lives. , North American ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... specialty pharmacies, has released an updated version of the HCV Treatment Path app ... treating chronic hepatitis C virus (HCV) infection. All of the latest HCV medications ...
(Date:7/25/2017)... ... July 25, 2017 , ... Creative Pharmacist and ... provide the Pharmacist eCare Plan to Computer-Rx pharmacies through the STRAND ... ability to develop the Pharmacist eCare Plan, a shared document detailing a patient’s ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... SPRING, Md. and RESEARCH TRIANGLE ... United Therapeutics Corporation (NASDAQ: UTHR ) announced ... financial results before the market opens on Thursday, July ... Therapeutics will host a teleconference on Thursday, July 27, ... accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  ...
(Date:7/19/2017)... 19, 2017  Mako Medical Laboratories partnered with Secretary ... Family Assistance Fund (MFA) to bring 140 soldiers back ... with their families one last time before being deployed. ... travel and logistics needed for these soldiers. "Mako Medical ... their families. We just wish we could bring them ...
(Date:7/14/2017)... July 13, 2017 It should come as no ... is in the midst of a crippling opioid epidemic. ... 1999, the number of overdose deaths from opiate-based medications has ... half a million dead from 2001 to 2015". During this ... hydrocodone has similarly quadrupled, drawing a compelling link between prescription ...
Breaking Medicine Technology: